Malaysia’s Avio Health has launched a proprietary clinical AI platform designed to unify health data and support the shift towards preventative, personalised care.

By integrating lab results, wearable data, genomics, imaging and patient histories, the platform provides clinicians and, soon, consumers with a comprehensive, actionable view of health status.

In current healthcare systems, medical and wellness data are often stored in isolated silos. Laboratory tests, imaging results, wearables and symptom logs typically exist in unconnected systems, limiting the ability to detect trends or anticipate health risks. This fragmentation challenges care providers and leaves patients with large volumes of unstructured, difficult-to-interpret information.

“Patients often undergo numerous tests and use multiple health devices, but the volume of data can quickly become overwhelming, especially when there’s no clear correlation to actual health biomarkers,” said Elvin Siew, founder of Avio Health. “Our platform connects those fragmented data points to uncover meaningful patterns. While we currently support clinicians, we’re also preparing to launch a direct-to-consumer model, giving individuals a simple, unified way to better understand and manage their health. We believe this will help reshape the future of healthcare from reactive to truly preventive.”

Despite access to heart rate variability, glucose monitoring and sleep tracking, most users of wearables receive no integrated insight into how those metrics relate to their health trajectory.

“We’re not adding more data, we’re making it meaningful,” said Siew. “Avio Health turns scattered health info into clear, proactive plans for real people.”

The platform uses a proprietary large language model (LLM) trained on medical data. Unlike general-purpose AI systems, Avio’s LLM is designed to interpret complex, multimodal health inputs and identify early patterns that may indicate underlying issues, even before symptoms emerge.

In one use case, a 42-year-old patient using several health tracking devices and undergoing routine lab tests reported persistent fatigue and brain fog. Traditional diagnostics found no abnormalities. However, when her data, ranging from hormone labs and wearable metrics to historical health records, was analysed through the Avio platform, the system flagged early signs of mitochondrial dysfunction and inflammation.

Based on this insight, her care team at Emagene Life (emagene.life) implemented a targeted protocol that included nutritional adjustments, peptide therapy and follow-up testing. Within 90 days, the patient reported significant energy and cognitive clarity improvement.

The technology stack includes a proprietary LLM for functional and preventative health applications, along with the integration of labs, genomics, imaging, symptoms and lifestyle data. It is interoperable with electronic health record (EHR) systems and wearable APIs. Adaptive clinical models learn and update with new data over time. A consumer-facing dashboard is in development for direct health insight and tracking.

Avio Health, already deployed in pilot programmes across south-east Asia and the USA, empowers clinicians in diagnostic labs, longevity clinics and wellness centres. Headquartered in Kuala Lumpur, Avio Health (www.avio.health) is expanding globally to serve institutional and individual healthcare markets.